Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls

Breast Cancer

Volumn 21, Issue 4, 2014, Pages 453-462

  Ando Tanabe, Noriko ^a   Iwamitsu, Yumi ^a   Kuranami, Masaru ^b   Okazaki, Shigemi ^a,c   Yasuda, Hiroe ^a   Nakatani, Yuki ^a   Yamamoto, Kenji ^b   Watanabe, Masahiko ^b   Miyaoka, Hitoshi ^b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Higashiyamato Hospital   (Japan)

Author keywords

Breast cancer; Chemotherapy; Cognitive function; Oncology; Psychological distress

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISTRESS SYNDROME; ESTIMATED INTELLIGENCE QUOTIENT; EXECUTIVE FUNCTION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KEIO VERSION WISCONSIN CARD SORTING TEST; LYMPH NODE DISSECTION; MASTECTOMY; MOOD CHANGE; NEUROPSYCHOLOGICAL TEST; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; RECALL; VERBAL FLUENCY TEST; VERBAL MEMORY; VISUAL MEMORY; WECHSLER MEMORY SCALE; BREAST NEOPLASMS; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; MENTAL STRESS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PSYCHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COGNITION; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEUROPSYCHOLOGICAL TESTS; PACLITAXEL; PROGNOSIS; STRESS, PSYCHOLOGICAL; TAXOIDS;

EID: 84904726703     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-012-0405-7     Document Type: Article

References (47)

1. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20(2):485-93. (Pubitemid 34072533)
2. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2000;18(14):2695-701. (Pubitemid 30463551)
3. Eberhardt B, Dilger S, Musial F, Wedding U, Weiss T, Miltner WH. Short-term monitoring of cognitive functions before and during the first course of treatment. J Cancer Res Clin Oncol. 2006;132(4):234-40. doi:10.1007/s00432- 005-0070-8. (Pubitemid 43144259)
4. Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer. 2009;115(8):1776-83. doi:10.1002/cncr.24192.
5. Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FS. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol. 2001;51(2):159-65. (Pubitemid 32435496)
6. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640-50. doi:10.1002/(SICI)1097-0142(19990201)85: 3〈640:AID-CNCR14〉3.0.CO;2-G. (Pubitemid 29075285)
7. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 1998; 90(3): 210-8. (Pubitemid 28114539)
8. Yamada TH, Denburg NL, Beglinger LJ, Schultz SK. Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci. 2010;22(1):48-54. doi:10.1176/appi.neuropsych.22.1.48.
9. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 2005;104(11):2499-507. doi:10.1002/cncr.21482. (Pubitemid 41691574)
10. Scherwath A, Mehnert A, Schleimer B, Schirmer L, Fehlauer F, Kreienberg R, et al. Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol. 2006;17(3):415-23. doi:10.1093/annonc/mdj108. (Pubitemid 43329577)
11. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology. 2006;15(5):422-30. doi:10.1002/pon.964. (Pubitemid 43826855)
12. Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncology. 2008;17(12):1189-95. doi:10.1002/pon.1342.
13. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. 2009;116(1):113-23. doi:10.1007/s10549-008-0114-2.
14. Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology. 2008;17(2):122-30. doi:10.1002/pon.1210. (Pubitemid 351279862)
15. Debess J, Riis JO, Engebjerg MC, Ewertz M. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat. 2010;121(1):91-100. doi:10.1007/s10549-010-0756- 8.
16. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer. 2007;109(9):1905-13. doi:10.1002/cncr.22610. (Pubitemid 46668557)
17. Mehlsen M, Pedersen AD, Jensen AB, Zachariae R. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology. 2009;18(3):248-57. doi:10.1002/pon.1398.
18. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, et al. The cognitive effects of chemotherapy in postmenopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat. 2010;123(1):25-34. doi:10.1007/s10549-009-0606-8.
19. McCaffrey RJ, Duff K, Westervelt HJ. Practitioner's guide to evaluating change with intellectual assessment instruments. NY: Springer; 2000.
20. McCaffrey RJ, Duff K, Westervelt HJ. Practitioner's guide to evaluating change with neuropsychological assessment instruments. NY: Springer; 2000.
21. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292-9. doi:10.1002/cncr.20272. (Pubitemid 38657875)
22. Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. 2008;110(1):143-52. doi:10.1007/s10549-007-9686-5. (Pubitemid 351793851)
23. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma? A prologue. Cancer. 2004;101(3):466-75. doi:10.1002/cncr.20393.
24. Cimprich B, So H, Ronis DL, Trask C. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology. 2005;14(1):70-8. doi:10.1002/pon.821. (Pubitemid 40124675)
25. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94(6):828-34. doi:10.1038/sj.bjc.6603029.
26. Buckelew SP, Hannay HJ. Relationships among anxiety, defensiveness, sex, task difficulty, and performance on various neuropsychological tasks. Percept Mot Skills. 1986;63(2 Pt 2):711-8.
27. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348-56. doi:10.1002/cncr.25098.
28. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. (Pubitemid 13098606)
29. Zigmond AS, Snaith RP, Kitamura T. Hospital Anxiety and Depression Scale (HAD scale). Archives of psychiatric diagnostics and clinical evaluation. Seishinka Shindan Gaku. 1993;4(3):371-2.
30. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-91.
31. Cohen J. A power primer. Psychol Bull. 1992;112(1):155-9.
32. Schilder CM, Seynaeve C, Linn SC, Boogerd W, Beex LV, Gundy CM, et al. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol Hematol. 2010;76(2):133-41. doi:10.1016/j.critrevonc.2009.11.001.
33. Reid-Arndt SA, Yee A, Perry MC, Hsieh C. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol. 2009;27(4):415-34. doi:10.1080/07347330903183117.
34. Golden CJ, Espe-Pfeifer P, Wachsler-Felder J. Neuropsychological interpretations of objective psychological tests. New York: Kluwer Academic/Plenum; 2000.
35. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc. 2009;15(6):951-62. doi:10.1017/S1355617709990567.
36. Dotson VM, Resnick SM, Zonderman AB. Differential association of concurrent, baseline, and average depressive symptoms with cognitive decline in older adults. Am J Geriatr Psychiatry. 2008;16(4):318-30. doi:10.1097/JGP. 0b013e3181662a9c.
37. Singh-Manoux A, Akbaraly TN, Marmot M, Melchior M, Ankri J, Sabia S, et al. Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study. J Clin Psychiatry. 2010;71(10):1379-85. doi:10.4088/JCP. 09m05349gry.
38. Biringer E, Mykletun A, Dahl AA, Smith AD, Engedal K, Nygaard HA, et al. The association between depression, anxiety, and cognitive function in the elderly general population - the Hordaland Health Study. Int J Geriatr Psychiatry. 2005;20(10):989-97. doi:10.1002/gps.1390. (Pubitemid 43055112)
39. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010;28(29):4434-40. doi:10.1200/JCO.2009.27.0827.
40. Biglia N, Moggio G, Peano E, Sgandurra P, Ponzone R, Nappi RE, et al. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med. 2010;7(5):1891-900. doi:10.1111/j.1743-6109.2010.01725.x.
41. Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219-27. doi:10.1097/JOM.0b013e3181d0bef7.
42. Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007;11(1):6-15. doi:10.1016/j.ejon.2006.02.005.
43. Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol. 2010;28(8):1294-300. doi:10.1200/JCO.2008.21.3553.
44. Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer. 2008;113(9):2431-9. doi:10.1002/cncr.23853.
45. Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3(4):223-32. doi:10.1007/s11764-009-0098-x.
46. Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res 2007; 16(4): 278-93 (discussion 94-301). doi:10.1177/1054773807306553.
47. Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010;19(9-10):1362-70. doi:10.1111/j.1365-2702.2009.03006.x.